NEW ORLEANS – In a significant transition for the field of reconstructive medicine, Babak J. Mehrara, MD, has officially assumed the presidency of The Plastic Surgery Foundation (The PSF). The organization, which serves as the philanthropic and intellectual engine supporting the research, charitable, and international endeavors of the American Society of Plastic Surgeons (ASPS), confirmed the appointment during Plastic Surgery The Meeting, the society’s premier annual scientific conference held in New Orleans.
Dr. Mehrara, a preeminent figure in oncologic reconstruction and lymphatic biology, took the helm on October 12, 2025. His tenure is set to run through October 18, 2026, a period expected to be defined by a renewed emphasis on bridging the gap between bench-side laboratory research and bedside clinical application.
The Appointment: A New Era for The PSF
The PSF plays a pivotal role in the global plastic surgery ecosystem, funding critical research, providing humanitarian aid, and fostering educational initiatives that transcend borders. Dr. Mehrara’s ascension to the presidency is widely viewed by industry peers as a strategic move to align the foundation with the rapidly evolving landscape of personalized medicine and regenerative surgery.
"It’s an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated during his inaugural address. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators. Throughout my presidency, I will champion new ways to strengthen and expand The Foundation’s mission of research and education."
Chronology of a Distinguished Career
To understand the weight of Dr. Mehrara’s appointment, one must examine the trajectory of a career defined by high-impact clinical work and rigorous scientific inquiry.
- Academic Foundations: Dr. Mehrara’s career has been characterized by a dual commitment to the classroom and the operating theater. His academic journey culminated in his role as Professor of Surgery at Weill Cornell Medical College, where he has been instrumental in mentoring the next generation of plastic surgeons.
- The MSK Tenure: Currently, Dr. Mehrara serves as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK). His leadership at one of the world’s most prestigious cancer centers has positioned him at the epicenter of reconstructive innovation.
- Endowed Leadership: As the holder of the Peter G. Cordeiro Endowed Chair in the Department of Surgery at MSK, he has leveraged institutional support to push the boundaries of what is possible in reconstructive surgery, particularly for patients recovering from the physiological trauma of cancer treatments.
- October 2025: The official transition occurred in New Orleans, marking the beginning of a 12-month term that will see the Foundation prioritize global outreach and the expansion of its research grants program.
Supporting Data: A Proven Track Record in Innovation
Dr. Mehrara’s reputation is not merely built on his titles, but on his prolific contributions to the global medical literature. With over 400 peer-reviewed publications to his name, his work serves as the bedrock for modern protocols in lymphatic management.
The Lymphatic Biology Laboratory
Perhaps the most significant evidence of Dr. Mehrara’s scientific impact is his stewardship of the National Institutes of Health (NIH)-funded Lymphatic Biology Laboratory at MSK. Under his direction, the lab has transitioned from theoretical exploration to clinical reality. Key focus areas include:
- Lymphedema Pathophysiology: Unraveling the molecular triggers that cause fluid retention and tissue fibrosis in post-surgical cancer patients.
- Translational Research: Developing novel surgical and non-surgical interventions that move beyond symptom management to address the underlying causes of lymphatic disruption.
- Grant Success: His laboratory’s ability to consistently secure NIH funding speaks to the caliber of research being conducted under his guidance—a skill set he intends to bring to The PSF to help early-career researchers navigate the complex landscape of grant acquisition.
Official Responses and Peer Perspective
The medical community has responded to the appointment with widespread optimism. Leaders within the ASPS have noted that Dr. Mehrara’s unique blend of surgical prowess and scientific rigor makes him the ideal candidate to navigate the financial and regulatory challenges currently facing the field.
"Dr. Mehrara represents the gold standard of the surgeon-scientist," remarked a fellow board member at the induction ceremony. "He doesn’t just see the patient in the operating room; he sees the biological mechanisms that necessitated the surgery. By bringing that perspective to the presidency of The PSF, he will undoubtedly increase the ‘return on investment’ for every research dollar the foundation allocates."
For his part, Dr. Mehrara has emphasized that the Foundation’s strength lies in its partnerships. He has signaled a desire to collaborate more closely with international health organizations to ensure that the innovations developed in Western academic centers reach underserved populations globally.
Implications for the Future of Plastic Surgery
The presidency of Dr. Mehrara comes at a critical juncture. As healthcare systems globally grapple with the rising costs of surgical care and the increasing complexity of patient cases, The PSF is tasked with ensuring that plastic surgery remains both innovative and accessible.
Driving High-Impact Research
Dr. Mehrara has identified "high-impact research" as a pillar of his term. This involves shifting focus toward projects that offer the greatest potential for patient outcome improvement. The foundation is expected to prioritize:
- Regenerative Medicine: Investing in tissue engineering to reduce the need for autologous tissue transfers.
- Digital Health Integration: Utilizing artificial intelligence to predict surgical outcomes and optimize preoperative planning.
- Outcomes Data: Building comprehensive registries that track long-term patient satisfaction and functional restoration.
Expanding Access and Equity
A central theme of Dr. Mehrara’s platform is the democratization of safe, effective plastic surgery. Reconstructive surgery is often viewed through the lens of aesthetic enhancement, yet for cancer survivors, it is a life-altering necessity. Dr. Mehrara plans to work with The PSF to advocate for better insurance coverage, improved surgical training in developing nations, and public education campaigns that demystify the reconstructive process.
Mentorship and the Pipeline
Perhaps the most personal aspect of his agenda is the mentorship of young surgeons. Recognizing that the cost of research can be a barrier to entry, Dr. Mehrara is focused on expanding scholarship and fellowship opportunities. "The future of this field depends on our ability to ignite the curiosity of the next generation," he noted. By creating a more robust support system for junior faculty, he aims to ensure that the pipeline of talent remains strong despite the increasing demands of modern surgical practice.
Conclusion: A Year of Transformation
As Dr. Mehrara settles into his role, the plastic surgery community watches with anticipation. His term is expected to be characterized by a departure from purely administrative leadership toward a more scientific, proactive approach.
By marrying his deep clinical experience at Memorial Sloan Kettering with a visionary outlook for The PSF, Dr. Mehrara is poised to redefine the Foundation’s role as more than just a funding body. He envisions it as a catalyst—a transformative force that will accelerate the pace of discovery, improve the lives of cancer survivors, and elevate the standard of care for patients across the globe.
As the industry moves through 2026, the focus will remain on the metrics of success: improved research funding, successful clinical trials, and the continued professional development of surgeons worldwide. With Dr. Mehrara leading the charge, the future of The Plastic Surgery Foundation appears not only secure but primed for a new era of medical breakthrough.
About the Author
